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Summary A consecutive series of 644 women who presented with breast nodularity between 1976 and 1982
have been followed up to determine their rate of subsequent breast cancer.
Fifteen women have developed breast cancer, 14 of these were among 352 women with an aspirated cyst
(relative risk 4.4). Women with multiple cysts had the highest risk and women with breast nodularity had no
excess risk. Review of histology specimens from those women who had undergone biopsy showed an excess of
florid epithelial hyperplasia in women who subsequently developed breast cancer and women with multiple
aspirated cysts were more likely to have florid epitheial hyperplasia. Multiple cysts are clinical markers of
histological breast proliferation and women who have had multiple breast cysts aspirated have an increased
risk of breast cancer and should be advised to practice regular self examination.
Cystic disease of the breast is the most common benign
disorder of the breast (Haagensen, 1971), exceeded only by
carcinoma in frequency.
Seven per cent of women in the Western World will have a
cyst aspirated in their lifetime, but microcystic change on
histology is much more common as in 58% of women under-
going breast biopsy (Page et al., 1978) and 23% of women at
postmortem (Dupont & Page, 1985) were found to have
cystic change. In 1971, Haagensen reported a 4-fold increased
risk of breast cancer in women who had undergone cyst
aspiration (Haagensen, 1971) but recently two large retro-
spective studies of patients undergoing breast biopsy for
benign disease failed to find any increased relative risk for
women who had cystic disease seen only in histological
review. (Page et al., 1978; Dupont & Page, 1985). The
authors found that only women with histological evidence of
proliferative disease (florid epithelial hyperplasia with or
without atypia) have an increased risk of breast cancer.
(Dupont & Page, 1985).
The differing conclusions reached by these studies led us to
examine the long term prognosis of women with benign
breast disease. This study seeks to determine if women who
have had a breast cyst aspirated have an increased risk of
breast cancer, and if so which group of women with cysts
have the highest relative risk.
Subjects and methods
A computerised record of women presenting to the Univer-
sity Department of Surgery Breast Clinic in the University
Hospital of Wales has been established since the mid 1970's.
Epidemiological information, clinical history of diagnosis are
recorded prospectively for all women when they attend. In
this study we have retrieved the names of all women with a
diagnosis of benign nodularity (formerly fibroadenosis;
fibrocystic disease) during the years 1976-1982 (inclusive)
from the computer. Six hundred and forty-four women with
this diagnosis were seen over this 7 year period. The clinical
diagnosis was made by cyst aspiration in 357 women and on
clinical mammographic or pathological grounds in the
remaining 287 who did not have a cyst aspirated. Both
groups have been traced to determine their subsequent breast
cancer risk. The method of tracing described by Sims (1973)
was used. If hospital notes contained no recent information,
the general practitioner and local family practitioner commit-
tee were contacted. Finally, the NHS central register was
consulted for current general practitioner registration or for
details of death. Referrals for breast disease and any other
serious illnesses during follow-up were noted.
Definitions
Aspirable palpable cysts were clinically detected cysts which
disappeared on aspiration. Microcysts and macrocysts refer
to histopathological entities seen on microscopy.
Histological review
Histological slides were also available for 91 women (14%)
who had undergone breast biopsy either at the initial visit or
during follow up. The slides were reviewed for this study by
a single pathologist (J.O.D.) without knowledge of the
clinical diagnosis, original histological report or subsequent
breast cancer development. Histological lesions were
classified using the system described by Dupont and Page
(1985). Particular attention was paid to the presence or
absence of epithelial hyperplasia. When present epithelial
hyperplasia was classified as mild, florid or atypical. Accord-
ing to Dupont and Page only florid atypical hyperplasia is
associated with increased risk of subsequent breast car-
cinoma. We made no attempt to quantify the relative
amounts of histological complexes within each biopsy speci-
men.
Statistical analysis
The expected frequency for breast cancer incidence was cal-
culated in 5 year age groups by multiplying the total woman
years in each age group by the age specific incidence rates for
breast cancer in England and Wales for the years 1980-86
(O.P.C.S. 1982). Confidence limits for breast cancer risk
relative to the general population were calculated using the
Poisson distributions. Internal comparison was also made,
comparing the relative risks of breast cancer between the
cysts and benign nodularity diagnoses by chi-squared tests
and by a chi-squared test for trend described by Armitage
(Armitage, 1971).
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Results
Tracing
Of the original 644 women seen with benign nodularity
(fibrocystic disease) between the years 1976-1982. Five
women (0.8%) were diagnosed as having breast cancer within
the first year of follow up and these women have been
excluded from further analysis. All women over 30 under-
went mammography at initial attendance and two of the five
women with cancer within 1 year of the clinical visit had
undergone cyst aspiration and were found to have mammo-
graphic abnormalities in the contralateral breast which on
biopsy proved to be due to invasive ductal carcinoma. The
remaining 639 women have been traced via their hospital
notes (446, 70%), their original GP (103, 16%) or via the
local family practitioner committees to a new GP (44, 7%).
Of the remaining women 34 (5%) were traced by writing to
the NHS Central Records Department in Southport to deter-
mine their current GP. Twelve women (2%) remain untraced.
Clinical diagnosis grouping
The 352 women who had palpable breast cysts aspirated were
significantly older (P <0.001) than the 287 women with
benign nodularity (and who had never had a cyst aspirated).
Multiple cysts were aspirated in 188 women either syn-
chronously or metachronously and 102 women had cysts
aspirated bilaterally. In the cyst group 37 (10.5%) women
gave a family history ofbreast cancer in a first degree relative
and nine (2.5%) of a family history of cyst formation.
Incidence ofbreast cancer
Among the total population of 639 women, 15 (2.3%)
developed invasive breast cancer, during a mean 7.2 years of
follow-up compared with an expected 5.1 cancers indicating
an overall relative risk of 2.9 (95% confidence limits 1.6 and
4.8).
Only one woman in the benign nodularity group developed
breast cancer which does not differ significantly from the
expected breast cancer rate while 14 women who had cysts
aspirated developed breast cancer which was 4.4 times the
expected incidence (P <0.001 Poisson test) (95% confidence
limits 2.4 and 7.3) (see Table I). This increased risk occurred
at all ages.
Women with multiple breast cysts were significantly more
likely to develop breast cancer than women in either the
solitary aspirated cyst group or the benign nodularity group
(Chi-squared test for trend = 12.15, P <0.01) (Armitage,
1971). Likewise, women who had bilateral breast cysts were
more likely to develop breast cancer (Chi-squared test for
trend 14.47, P <0.01). A family history of breast cancer did
not increase the risk of women with aspirated cysts develop-
ing breast cancer.
Patients with breast cancer
Two women out of the 15 patients with breast cancer were
diagnosed between 1 and 2 years after first attendance at
clinic. The remaining 13 cases were diagnosed between 3 and
12 years (mean 5.1 years) after the first cyst aspiration. One
of the two women who developed cancer within 2 years had
a past history of having bilateral cyst aspirations some 2
Table I Incidence of breast cancer on follow-up
Expected Observed
Diagnosis n cancersa cancers Relative risk
Benign nodularity 287 1.91 1 0.52
Aspirated cysts 352 3.18 14 4.4b
aExpected on age specific incidence in England and Wales in years
1980-84 (OPCS 1982-88). bPoisson test (P <0.001).
years before at another surgical clinic. She subsequently
developed a left sided mammographic abnormality, 13
months after being seen with a right cyst. The other patient
had a total of six cysts aspirated from both breasts over a
period of 13 months when she was noted to have a residual
mass following cyst aspiration. Biopsy proved this to be a
1 cm poorly differentiated invasive carcinoma. In neither case
despite review of the hospital notes and mammograms do we
feel a breast cancer was missed initially. Six women had
undergone bilateral cyst aspiration and developed breast
cancer on both sides equally. Seven out of the eight women
who had unilateral breast cysts developed breast cancer on
the same side as their cyst. Two women presented with
impalpable mammographic abnormalities and nine women
presented with lumps which were solid on aspiration. Three
women had inoperable breast cancer, one had a positive bone
scan, one presented with advanced local breast cancer and
the third presented to the physicians with postrenal failure
secondary to retroperitoneal infiltration by lobular car-
cinoma. Ten women had node negative carcinoma out of the
12 who underweent mastectomy and axillary clearance. Two
women have died from their breast cancer.
Histology
Histological review of the biopsies from 91 women (14%)
revealed 62 (68%) had microcysts, 33 (36%) macrocysts (22
apocrine, 11 non-apocrine) and 64 (70%) apocrine change.
Twenty-six (28%) women had mild epithelial hyperplasia, 17
(20%) florid epithelial hyperplasia without atypia and two
patients had hyperplasia with atypia, both in the cyst group.
(See Table II). Five women who underwent biopsy subse-
quently developed breast cancer, and all five had apocrine
metaplasia and four of five florid hyperplasia on histological
review.
Florid epithelial hyperplasia with or without atypia was
seen in 19 women and was the only histological change
predictive of a subsequent risk of cancer (Chi-squared test
for trend = 10.16, P <0.01). When the histological findings
were correlated with clinical features, women with multiple
aspirable cysts were significantly more likely to have florid
epithelial hyperplasia in their biopsy specimens (Chi-squared
test for trend = 14.63 P <0.01, Table II).
Discussion
The detailed pathological work of Page and Dupont (Page et
al., 1978; Dupont & Page, 1985) was widely seen as disprov-
ing Haagensen's findings that women who had breast cysts
were at an increased risk of breast cancer (Haagensen, 1971).
Page and Dupont's study was a histological retrospective
review of 10,542 breast biopsies from 3,303 women who were
followed up for a mean of 17 years and florid epithelial
hyperplasia with or without atypia was the only histological
risk factor for subsequent breast cancer development. Their
Table II Histological findings in 91 (14%) women who underwent
breast biopsy
Clinical diagnosis
Benign Solitary Multiple Observed
Histological nodularity cyst cysts no. of
findings (n = 19) (n = 19) (n =45) cancersa
Apocrine change 17 (63%) 14 (74%) 33 (74%) 5
Epithelial hyperplasia
None 23 (81%) 12 (64%) 14 (30%) 0
Mild 4 (15%) 4 (21%) 18 (40%) 1
Florid 1 (4%) 3 (16%) 13 (30%) 4
Epithelial atypia 0 1 1 1
Florid epitheliosis: Multiple cysts vs nodularity. Test for trend
P <0.01. aFive patients developed breast cancer in the women who
underwent biopsy and their biopsies all showed apocrine metaplasia
but with varying degrees of co-existing hyperplasia.BREAST CYSTS AND CANCER RISK 955
incidence of gross cysts on histology was 23% and post-
mortem studies suggest an even higher incidence (Davies et
al., 1964) yet it is estimated that only 7% of women in the
Western world will develop a clinically aspirable breast cyst
in their lifetime (Haagensen, 1971). No information is
available on the clinical cyst aspiration rate in the Page and
Dupont paper. Modern practice is to aspirate breast cysts
and histology is rarely available in contrast to the older series
(Page et al., 1978; Dupont & Page, 1985; Davies et al., 1964)
and thus direct comparison between studies is difficult.
Haagensen's original finding of an increased breast cancer
risk in women who have had aspiration of a breast cyst has
been sustained in this study. Two other clinical studies of
breast cancer risk following cyst aspiration have reached
similar conclusions (Jones & Bradbeer, 1980; Harrington &
Lesnick, 1981). This study is based on patients with aspirated
cysts and confirms the previous work (Jones & Bradbeer,
1980; Harrington & Lesnick, 1987 & Haagensen, 1971), but
additionally our histological data confirms that florid
epithelial hyperplasia with or without atypia is the most
important histological risk factor for subsequent breast
cancer as did Dupont and Page. Histological macrocysts
were common in both groups of women who had been
biopsied, but were not a risk factor for subsequent breast
cancer unlike clinically palpable cysts. Additionally, women
who had undergone multiple cysts aspirations had the highest
cancer risk clinically. Thus the best clinical marker for
predicting breast cancer risk, multiple cysts, is significantly
associated with underlying florid epithelial hyperplasia, the
best histological risk marker. This may partly explain the
apparent difference in risk of breast cancer between previous
clinical and histological studies.
This study showed no increased risk of breast cancer for
women who attended the breast clinic with benign nodularity
without having a cyst aspirated (generally known as fibrocys-
tic disease) unlike an earlier Cardiff study (Roberts et al.,
1984). The excess risk observed in this study is greater than
previously reported (Haagensen, 1971; Jones & Bradbeer
1980; Harrington & Lesnick, 1981; Roberts et al., 1984) but
other studies have not analysed risk for aspirated cysts
separately from biopsy or mammographically proven cysts.
Women with benign nodularity in this study include a
group of women with biopsy proven microcystic disease yet
they had no increased risk. We must therefore postulate that
palpable aspirable cysts are markers of underlying pro-
liferative breast disease and carry a risk in excess of those
women with histological microcyst formation, with multiple
and bilateral palpable cysts carrying the highest risk. This
finding supports our belief that macrocysts should be
regarded simply as a normal involutional phenomen (Hughes
et al., 1987) whereas cysts that become clinically evident
represent real disease.
Although a relative risk of 4.4 times normal appears high
it represents only 14 cases in a population of 352 women
followed for an average of over 7 years. The majority of the
188 women with multiple cysts were under continued surveil-
lance and had a heightened awareness of the importance of
self-examination in which they were well practised (Roberts
et al., 1984).
Current surgical practice is to discharge most women who
have cysts aspirated from follow-up once they stop forming
new cysts. As we have demonstrated an increased risk of
breast cancer in this group, a case could be made for con-
tinued follow-up but the workload of a surgical outpatients
clinic would be significantly increased. A better approach
would be to define further sub-groups within the multiple
cyst group of women at the highest risk who could then be
followed more closely. Possibilities under study include cyst
electrolyte analysis (Miller et al., 1983), or serial cyst protein
analysis (Haagensen et al., 1979). Another approach would
be to suppress cyst formation by drug therapy. Danazol
therapy is reported to reduce the number offrequency of new
cysts (Dhont et al., 1979) but it is not known whether such
therapy has any effect on cancer risk.
Several factors have been shown to be associated with an
increased risk of subsequent breast cancer and women who
have cysts aspirated should be encouraged to undertake
breast self-examination to detect early reappearance of cysts
and aid early diagnosis of any cancer that develops.
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